Alebund Pharmaceuticals (Jiangsu) Limited (HKG:9637)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
28.80
+0.30 (1.05%)
At close: Sep 4, 2026

HKG:9637 Statistics

Total Valuation

HKG:9637 has a market cap or net worth of HKD 9.79 billion. The enterprise value is 8.84 billion.

Market Cap9.79B
Enterprise Value 8.84B

Important Dates

The last earnings date was Wednesday, August 26, 2026.

Earnings Date Aug 26, 2026
Ex-Dividend Date n/a

Share Statistics

HKG:9637 has 339.85 million shares outstanding.

Current Share Class 227.12M
Shares Outstanding 339.85M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 2.25%
Owned by Institutions (%) 24.21%
Float 97.78M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 69.15
PB Ratio 6.02
P/TBV Ratio 6.06
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 62.48
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 9.81, with a Debt / Equity ratio of 0.41.

Current Ratio 9.81
Quick Ratio 9.69
Debt / Equity 0.41
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -12.51

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) -30.85%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee 837,525
Profits Per Employee -4.81M
Employee Count 169
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 31.11
200-Day Moving Average n/a
Relative Strength Index (RSI) 42.43
Average Volume (20 Days) 421,950

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, HKG:9637 had revenue of HKD 141.54 million and -812.52 million in losses. Loss per share was -2.98.

Revenue141.54M
Gross Profit 114.61M
Operating Income -719.29M
Pretax Income -813.56M
Net Income -812.52M
EBITDA -654.76M
EBIT -719.29M
Loss Per Share -2.98
Full Income Statement

Balance Sheet

The company has 1.61 billion in cash and 665.72 million in debt, with a net cash position of 943.62 million or 2.78 per share.

Cash & Cash Equivalents 1.61B
Total Debt 665.72M
Net Cash 943.62M
Net Cash Per Share 2.78
Equity (Book Value) 1.63B
Book Value Per Share 4.78
Working Capital 1.47B
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Depreciation & Amortization 65.30M
Net Borrowing n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin 80.97%
Operating Margin -508.18%
Pretax Margin -574.79%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

HKG:9637 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -8.30%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Analyst Forecast

The average price target for HKG:9637 is 46.69, which is 62.12% higher than the current price. The consensus rating is "Strong Buy".

Price Target 46.69
Price Target Difference 62.12%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (3Y) 208.40%
EPS Growth Forecast (3Y) n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score n/a